GMPify Procedural Map Series

GMP Maps

Free pharmaceutical procedural maps built from primary regulatory sources. Every decision point. Every regulatory citation. Designed to be used - in training sessions, at your desk and on the manufacturing floor.

Working in food manufacturing? View the Food GMP Maps →

FreeAlways
GrowingSeries
PrimaryRegulatory sources
Current2025 and 2026 enforcement
Built from 21 CFR Parts 210 and 211 Built from EU GMP EudraLex Volume 4 Built from ICH Q10, Q9(R1) 2023 Built from FDA Guidance Documents Updated to reflect 2025 and 2026 enforcement data
🔓
Subscriber Perk

Every map has an Enhanced Edition

The free maps on this page cover the full procedural workflow. GMPify subscribers get access to the Enhanced Edition of each map on learn.gmpify.com, with deeper detail built for daily use and inspection prep.

Full regulatory text panels Inspection finding patterns Best practice guidance Self-assessment checklists Site annotation fields Print-to-PDF optimization
Unlock Enhanced Maps →
1
Quality Systems

OOS Investigation Procedural Map

The complete two-phase FDA OOS investigation framework. Phase I laboratory investigation through Phase II full manufacturing investigation. Every decision point, timeline and scope extension requirement from 21 CFR 211.192 and FDA OOS Guidance 2022.

21 CFR 211.192 21 CFR 211.165(f) FDA OOS Guidance 2022 ICH Q10 Barr Laboratories
2
Quality Systems

CAPA Lifecycle Map

From problem identification through root cause analysis, corrective action implementation and effectiveness verification to closure. Includes VOE design requirements and the 2026 warning letter case patterns.

21 CFR 211.192 ICH Q10 S3.2.2 21 CFR 820.100
3
Quality Systems

Deviation Management and Root Cause Analysis Map

Deviation classification, impact assessment, root cause methodology selection and CAPA integration. Includes the Apotex 2025 warning letter pattern and 5 Why versus Ishikawa selection criteria.

21 CFR 211.192 EU GMP Chapter 1 ICH Q9(R1)
4
Regulatory

Change Control Decision Map

From change proposal through risk assessment, regulatory classification and implementation to post-implementation review. Includes PAS, CBE-30 and CBE-0 decision logic and ICH Q12 PACMP pathway.

21 CFR 211.100 21 CFR 314.70 ICH Q12
5
Microbiology

Environmental Monitoring Programme Workflow

Cleanroom monitoring programme design, alert and action level setting, exceedance investigation and trend analysis. Built from EU GMP Annex 1 2022 and FDA aseptic processing guidance.

EU GMP Annex 1 FDA Aseptic Guide USP 1116
6
Regulatory

FDA 483 Response Workflow

From 483 receipt through observation assessment, response drafting, CAPA commitment and follow-up. Includes the March 2026 FDA Draft Guidance requirements and warning letter escalation risk factors.

FDA 483 Guidance 2026 21 CFR 211.192 ICH Q10
7
Validation

Cleaning Validation Lifecycle Map

Three-stage cleaning validation lifecycle from cleaning process design through qualification and continued verification. Includes MACO calculation pathway and HBEL versus legacy limit decision logic.

21 CFR 211.67 EU Annex 15 EMA HBEL Guideline
8
Quality Systems

Batch Release Decision Flowchart

From batch completion through quality unit review, specification assessment, deviation and OOS status review to release or rejection decision. Covers both FDA and EU GMP qualified person release frameworks.

21 CFR 211.22 21 CFR 211.165 EU GMP Chapter 2
9
Quality Systems

Supplier Qualification Workflow

From supplier identification through qualification assessment, approval, quality agreement and ongoing monitoring. Includes the 2026 contract manufacturing enforcement framework and audit programme requirements.

21 CFR 211.84 ICH Q10 EU GMP Chapter 7
10
Validation

Stability Study Design Map

From product classification through study design, storage condition selection, time point planning and shelf life determination. Built from ICH Q1A(R2) and the 2025 Draft ICH Q1 revision.

ICH Q1A(R2) ICH Q1E 21 CFR 211.166
11
Microbiology

Cleanroom Classification and Qualification Workflow

From design and specification through testing and certification, documentation and release, to requalification and maintenance. Includes the full ISO class to GMP grade equivalence table. Built from ISO 14644-1:2015, ISO 14644-2:2015, EU GMP Annex 1 2022 and 21 CFR 211.42.

ISO 14644-1:2015 EU GMP Annex 1 2022 21 CFR 211.42
12
Microbiology

Water System Monitoring Workflow

From design and qualification through sampling and testing, trending and review, to maintenance and recertification. Covers PW, WFI and Pure Steam grade requirements. Built from USP <1231>, USP <645>, EU GMP Annex 1 2022 and 21 CFR 211.42.

USP <1231> USP <645> 21 CFR 211.42
13
Microbiology

Sterility Testing Workflow

From sample selection and preparation through test execution, result interpretation and investigation, to release decision and documentation. Covers membrane filtration vs direct inoculation. Built from USP <71>, USP <1071>, EU GMP Annex 1 2022 and 21 CFR 211.167.

USP <71> USP <1071> 21 CFR 211.167
14
Microbiology

Bioburden Testing Workflow

From sample and method selection through test execution, result interpretation and trending, to investigation and release decision. Covers the complete USP <1111> product category structure. Built from USP <61>, USP <1111>, EU GMP Annex 1 2022 and 21 CFR 211.113.

USP <61> USP <1111> 21 CFR 211.113
15
Microbiology

Media Fills (Aseptic Process Simulation) Workflow

From design and planning through execution, incubation and reading, to evaluation and requalification. Covers worst-case design requirements and acceptance criteria. Built from EU GMP Annex 1 2022, FDA Aseptic Processing Guidance 2004, PDA TR 22/28 and ISO 13408-1.

EU GMP Annex 1 2022 FDA Aseptic Guidance 2004 ISO 13408-1
16
Microbiology

Contamination Control Strategy (CCS) Workflow

From risk assessment and strategy development through control implementation, monitoring and verification, to review and continuous improvement. Includes the full eight-component CCS framework. Built from EU GMP Annex 1 2022 Section 2.2, ICH Q9(R1) and ICH Q10.

EU GMP Annex 1 2022 ICH Q9(R1) ICH Q10
17
Microbiology

Trending (Statistical Trend Analysis) Workflow

From data collection and baseline through statistical analysis and limit setting, ongoing trend review, to signal response and adjustment. Covers control charts, percentile methods and run rules. Built from EU GMP Annex 1 2022, ICH Q10, USP <1116> and PDA TR 13.

EU GMP Annex 1 2022 USP <1116> PDA TR 13
18
Microbiology

Microbiological Investigations Workflow

From initial assessment and laboratory investigation through manufacturing and process investigation, root cause and impact assessment, to CAPA and closure. Built on the two-phase model from the Barr decision. Built from 21 CFR 211.192, FDA OOS Guidance 2006 and ICH Q10.

21 CFR 211.192 FDA OOS Guidance 2006 ICH Q10
19
Microbiology

Isolate Identification Workflow

From isolate recovery and triage through method selection and testing, result interpretation and risk assessment, to library management and trending. Covers phenotypic vs genotypic methods. Built from USP <1113>, EU GMP Annex 1 2022 and PDA TR 13.

USP <1113> EU GMP Annex 1 2022 PDA TR 13
20
Quality Systems

OOT (Out-of-Trend) Investigation Workflow

From detection and criteria through laboratory assessment, process and product investigation, to disposition and programme adjustment. Covers regression analysis, control charts and percent change criteria. Built from ICH Q1E, USP <1010>, 21 CFR 211.166 and 211.192.

ICH Q1E USP <1010> 21 CFR 211.166
21
Quality Systems

Complaint Handling Workflow

From receipt and initial triage through investigation and classification, root cause and impact assessment, to response, CAPA and closure. Covers critical, major and minor complaint classification. Built from 21 CFR 211.198, EU GMP Chapter 8 and ICH Q10.

21 CFR 211.198 EU GMP Chapter 8 ICH Q10
22
Quality Systems

Internal Audit (Self-Inspection) Workflow

From audit planning and scheduling through execution, findings documentation and classification, to CAPA and follow-up verification. Covers auditor independence and risk-based scheduling. Built from EU GMP Chapter 9, ICH Q10 and 21 CFR 211.22.

EU GMP Chapter 9 ICH Q10 21 CFR 211.22
23
Quality Systems

Risk Management (ICH Q9) Workflow

From initiation and planning through identification and analysis, evaluation and control, to communication and review. Covers FMEA, HACCP, Fault Tree Analysis and risk ranking tools. Built from ICH Q9(R1), ICH Q10 and EU GMP Annex 20 / Part III.

ICH Q9(R1) ICH Q10 EU GMP Annex 20
24
Quality Systems

Annual Product Review (APR) Workflow

From data collection and scope definition through compilation and trend analysis, evaluation and conclusion, to reporting, CAPA and follow-up. Covers required APR content per 21 CFR 211.180(e). Built from 21 CFR 211.180(e), EU GMP Chapter 1 and ICH Q10.

21 CFR 211.180(e) EU GMP Chapter 1 ICH Q10
25
Manufacturing

Batch Record Review Workflow

The complete review pathway for executed batch records, from completeness and accuracy checks through deviation and OOS linkage to documented QA review before release.

21 CFR 211.188 21 CFR 211.192 21 CFR 211.194 EU GMP Chapter 4
26
Regulatory

Change Notification Workflow

How to classify a post-approval change, decide the reporting category, and submit it to the right authority, from FDA supplements to EU variations.

21 CFR 314.70 FDA SUPAC Guidance EC 1234/2008
27
Clinical

Clinical Trial Workflow

The end-to-end clinical trial pathway from protocol and approvals through conduct, safety reporting, and close-out under GCP, with the controls sponsors and sites must apply at each stage.

ICH E6(R2) 21 CFR Part 312 EU CTR 536/2014 ICH E2A
28
Manufacturing

Cross Contamination Prevention Workflow

A risk-based pathway for preventing cross-contamination in shared facilities, from hazard identification and health-based exposure limits to controls, verification, and review.

EMA HBEL Guideline 2014 EU GMP Chapter 3 EU GMP Chapter 5 ICH Q9(R1)
29
Quality Systems

Data Integrity Investigation Workflow

The structured pathway for investigating a suspected data integrity event, from detection and containment through scope assessment, root cause, and corrective action.

21 CFR Part 211 FDA Data Integrity Guidance ALCOA+ EU GMP Annex 11
30
Validation

Equipment Qualification Workflow

The equipment qualification lifecycle from user requirements and design review through IQ, OQ, PQ, and periodic review, built on a risk-based approach.

EU GMP Annex 15 ASTM E2500 ICH Q9(R1) 21 CFR 211.63
31
Regulatory

EU Inspection Workflow

What to do before, during, and after an EU GMP inspection, from notification and preparation to the inspection itself, the report, and the response.

Directive 2001/83/EC EU GMP Chapter 1 Compilation of Union Procedures
32
Regulatory

FDA Inspection Workflow

The full FDA inspection pathway for drug manufacturers, from arrival and credentials through daily management, Form 483, and the post-inspection response.

FD&C Act Section 704 21 CFR Part 211 FDA Investigations Operations Manual
33
Manufacturing

Gowning Workflow

The step-by-step gowning sequence for controlled and aseptic areas, with the qualification, behaviour, and monitoring requirements that support it.

EU GMP Annex 1 2022 ISO 14644-5 21 CFR 211.28
34
Regulatory

Health Canada Inspection Workflow

The Health Canada GMP inspection pathway for drug establishments, from notification through the inspection, observations, and the response to the inspector.

Food and Drugs Act Food and Drug Regulations C.02 GUI-0001 GUI-0023
35
Manufacturing

Line Clearance Workflow

The line clearance sequence between batches and products, covering removal of materials and documents, verification, and release of the line to start.

21 CFR 211.67 21 CFR 211.105 EU GMP Chapter 5 ICH Q7
36
Manufacturing

Material Flow Workflow

How materials move through a GMP facility from receipt and sampling to storage, dispensing, and production without mix-up or contamination.

EU GMP Chapter 3 EU GMP Chapter 5 21 CFR 211.80 to 211.87 ICH Q7
37
Validation

Analytical Method Validation Workflow

The analytical method lifecycle from the analytical target profile through validation parameters, system suitability, transfer, and ongoing performance verification.

ICH Q2(R2) USP <1225> ICH Q14 21 CFR 211.165(e)
38
Clinical

Monitoring Visits Workflow

The monitoring visit pathway from planning and preparation through source data verification, issue escalation, the visit report, and follow-up.

ICH E6(R2) Section 5.18 21 CFR 312.50 FDA Risk-Based Monitoring Guidance
39
Manufacturing

Personnel Flow Workflow

How people move through controlled manufacturing areas, covering entry, gowning, airlock use, and exit to protect product and prevent contamination.

EU GMP Annex 1 2022 EU GMP Chapter 2 21 CFR 211.28 ICH Q7
40
Validation

Process Validation Workflow

The three-stage process validation lifecycle from process design through qualification to continued process verification.

FDA Process Validation Guidance 2011 EU GMP Annex 15 ICH Q8/Q9/Q10/Q11
41
Clinical

Protocol Deviations Workflow

How to identify, document, classify, and report protocol deviations in a clinical trial, including important deviations and corrective action.

ICH E6(R2) Section 4.5 EU CTR 536/2014 Art. 52 21 CFR 312.66
42
Regulatory

Recall Process Workflow

The drug recall pathway from the decision to recall through classification, notification, effectiveness checks, and termination.

21 CFR Part 7 Subpart C FDA RPM Chapter 7 Health Canada RG-1
43
Clinical

SAE Reporting Workflow

The serious adverse event reporting pathway for clinical trials, from site identification through sponsor assessment and expedited reporting to regulators.

ICH E2A 21 CFR 312.32 EU CTR 536/2014 Art. 41-43 ICH E2B(R3)
44
Manufacturing

Tech Transfer Workflow

The technology transfer pathway from planning and gap assessment through process and method transfer to verification at the receiving site.

ICH Q10 WHO TRS 961 Annex 7 EU GMP Chapter 7
45
Clinical

TMF Management Workflow

Trial master file management from the filing plan and set-up through contemporaneous filing, quality review, and inspection readiness.

ICH E6(R2) Section 8 TMF Reference Model EU CTR 536/2014 21 CFR 312.57
46
Regulatory

Warning Letter Response Workflow

How to respond to an FDA warning letter, from the first read and team assembly through investigation, corrective action, and follow-up communication.

FD&C Act Section 705 21 CFR Part 7 FDA Regulatory Procedures Manual Ch. 4

How to use GMP Maps

01 Use in training sessions

Print or display any map during team training to walk through the correct procedural sequence step by step. Every decision point references the applicable regulation so your team understands the why not just the what.

02 Use for inspection preparation

Review the relevant map before an FDA or EU GMP inspection to confirm your procedures align with the regulatory expectations shown at each decision point. Identify gaps before the investigator does.

03 Use alongside GMPify courses

Each map corresponds to a GMPify course that covers the regulatory content in depth. The map gives you the procedural framework. The course gives you the understanding behind every step.

Go deeper with GMPify courses

Each procedural map is built from the same primary regulatory sources as the corresponding GMPify course. The map gives you the framework. The course gives you the regulatory depth, case examples and knowledge checks that prepare you for inspection.